Alembic company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

getalembic.com

Founded Year

2018

Stage

Seed VC | Alive

Total Raised

$9M

Last Raised

$5.2M | 8 mos ago

About Alembic

Alembic provides a marketing interface that includes one interface for social, email, direct mail, and analytics.

Alembic Headquarter Location

350 Townsend St Suite 210

San Francisco, California, 94107,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Alembic

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Alembic is included in 1 Expert Collection, including Targeted Marketing Tech.

T

Targeted Marketing Tech

329 items

This Collection includes companies building technology that enables marketing teams to identify, reach, and engage with consumers seamlessly across channels.

Alembic Patents

Alembic has filed 5 patents.

The 3 most popular patent topics include:

  • Piperazines
  • Benzamides
  • Cannabinoids
patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/29/2019

3/2/2021

Metal halides, Benzamides, Piperazines, Water ice, Sodium compounds

Grant

Application Date

1/29/2019

Grant Date

3/2/2021

Title

Related Topics

Metal halides, Benzamides, Piperazines, Water ice, Sodium compounds

Status

Grant

Latest Alembic News

Alembic Pharma Gets Final U.S. FDA Nod For Generic Version Of Arformoterol Tartrate Inhalation Solution

May 11, 2022

4:19 PM IST, 11 May 2022 4:19 PM IST, 11 May 2022 4:19 PM IST, 11 May 2022 Save Alembic Pharmaceuticals Ltd. on Wednesday said it has received final approval from the U.S. health regulator for its generic version of Arformoterol Tartrate inhalation solution indicated for long-term treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease. Alembic Pharmaceuticals Ltd. on Wednesday said it has received final approval from the U.S. health regulator for its generic version of Arformoterol Tartrate inhalation solution indicated for long-term treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease. The approval by the U.S. Food & Drug Administration for the abbreviated new drug application for Arformoterol Tartrate inhalation solution is for strength of 15 mcg (base)/2 mL unit-dose vial, the company said in a statement. The approved ANDA is therapeutically equivalent to the reference-listed drug product, Brovana inhalation solution, 15 mcg/2 mL, of Sunovion Pharmaceuticals Inc, it added. Arformoterol Tartrate inhalation solution is indicated for long-term, twice daily administration in the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema, the company said. This ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies Pvt., it added. Citing IQVIA data, the company said Arformoterol Tartrate inhalation solution, 15 mcg (base)/2 mL unit-dose vial, had an estimated market size of $251 million for the 12 months ended December 2021. Alembic said it has a cumulative total of 167 ANDA approvals (143 final approvals and 24 tentative approvals) from U.S. FDA, including this second inhalational ANDA approval. Stay Updated With Business News On BQ Prime Get Regular Updates

Alembic Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Alembic Rank

  • When was Alembic founded?

    Alembic was founded in 2018.

  • Where is Alembic's headquarters?

    Alembic's headquarters is located at 350 Townsend St, San Francisco.

  • What is Alembic's latest funding round?

    Alembic's latest funding round is Seed VC.

  • How much did Alembic raise?

    Alembic raised a total of $9M.

  • Who are Alembic's competitors?

    Competitors of Alembic include Brew.

You May Also Like

Databook Logo
Databook

Databook's Customer Intelligence Platform accelerates enterprise sales performance at scale with three integrated products: Databook Intent Dashboard, Databook Insights Platform, and Databook Sales Decks. Databook Intent Dashboard improves Marketing-to-Sales performance while decreasing costs by helping customer-facing teams prioritize the companies most likely to buy. The Databook Insights Platform accelerates qualified pipeline and top-line growth by delivering strategic value and offering a hyper-personalized customer experience. Databook Sales Decks increase sales organization productivity at scale by enabling 1-click, dynamic, and empathic customer content that delivers to the customer's perspective.

C
Crayon

Crayon offers a market and competitive intelligence platform that enables businesses to track, analyze, and act on market movements from competitors, customers, and partners. Crayon's software-driven approach to market intelligence allows businesses to get more data, surface critical signals, and act on that intelligence in real-time.

Klue Logo
Klue

Klue's platform combines information from co-workers with bot-collected intel to create battle cards and dynamic dashboards that display competitor activity. Klue collects data and uses AI to surface competitive intelligence for businesses shared into one central location. Users share real-time intel through Klue's battlecards, newsletters, self-serve features, and integrations. Users can also track competitors with website page monitoring, keyword insights, content tracking, and news monitoring.

B
Brew

Brew is a real-time market intelligence platform intended to amplify marketing's impact internally and externally. It combines the advantages of online marketing with the engagement rates of live events and continuously adapts to distill relevant insights. It was founded in 2019. It is based in Tel Aviv, Israel.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.